A Greinacher. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antibodies/pharmacologyAntibodies/physiologyAnticoagulants/adverse effectsAnticoagulants/therapeutic useChondroitin Sulfates/pharmacologyDermatan Sulfate/pharmacologyFemaleFondaparinuxHeparin/adverse effectsHeparin/immunologyHeparin/metabolismHeparitin Sulfate/pharmacologyHumansMalePlatelet Activation/immunologyPlatelet Factor 4/metabolismPolysaccharides/therapeutic useSerotonin/metabolismThrombocytopenia/drug therapyThrombocytopenia/etiologyThrombocytopenia/immunologyThromboembolism/prevention & control
Substances： See more » AntibodiesAnticoagulantsPolysaccharidesDermatan SulfateSerotoninPlatelet Factor 4HeparinChondroitin SulfatesHeparitin SulfateFondaparinux
Year: 2011 PMID： 21929685 DOI： 10.1111/j.1538-7836.2011.04511.x
Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824